Loading...
Chemical structure of CCG215022

GC19090

CCG215022

Also known as 4-[4-fluoro-3-(pyridin-2-ylmethylcarbamoyl)phenyl]-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxamide

CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0·15±0·07 uM, 0·38±0·06 uM and 3·9±1 uM for GRK2, GRK5 and GRK1, respectively

ChemicalCAS1813527-81-9MW499.5FormulaC26H22FN7O3
CAS number
1813527-81-9
Molecular weight
499.5
Formula
C26H22FN7O3
Solubility
DMSO ： ≥ 28 mg/mL (56·06 mM)
InChIKey
BLMBNKDQXGINRE-UHFFFAOYSA-N
Catalogue number
GC19090
Brand
GLPBIO
Computed properties PubChem CID 118888941 · XLogP 1.5 · TPSA 141 Ų · H-bond donors 5
XLogP
1.5
TPSA
141 Ų
H-bond donors
5
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
37

SMILES CC1=C(C(NC(=O)N1)C2=CC(=C(C=C2)F)C(=O)NCC3=CC=CC=N3)C(=O)NC4=CC5=C(C=C4)NN=C5

Computed descriptors from PubChem (CID 118888941), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.